PSNL Personalis, Inc.

Personalis, Inc. provides genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.

$23.00  -0.14 (-0.61%)
As of 04/09/2021 15:59:50 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  06/20/2019
Outstanding shares:  43,769,836
Average volume:  928,565
Market cap:   $1,007,581,625
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    71535D106
ISIN:        US71535D1063
Sedol:      BJQ0608
Valuation   (See tab for details)
PE ratio:   -24.41
PB ratio:   6.44
PS ratio:   12.81
Return on equity:   -21.18%
Net income %:   -52.49%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy